Information

Information

TowardPi believes in long-term value and adheres to a democratic company management model, with the spirit of scientists at its core
Your location:
Homepage
/
/
/
Conclusion of Prof. Min Wang on TowardPi Webinar

Conclusion of Prof. Min Wang on TowardPi Webinar

  • Categories:Academy
  • Time of issue:2023-07-28 11:56
  • Views:

(Summary description)The evaluation result for retinal vasculature diseases by Ultra-wide-field Swept Source (UWF-SS) OCTA is almost IDENTICAL to UWF-Fundus Fluorescein Angiography (FFA, invasive). Combination of UWF-SS-OCTA, UWF-Enface and OCT provides more information than FFA. UWF choroidal OCTA offers a new approach to explore choroidal diseases.

Conclusion of Prof. Min Wang on TowardPi Webinar

(Summary description)The evaluation result for retinal vasculature diseases by Ultra-wide-field Swept Source (UWF-SS) OCTA is almost IDENTICAL to UWF-Fundus Fluorescein Angiography (FFA, invasive).
Combination of UWF-SS-OCTA, UWF-Enface and OCT provides more information than FFA.
UWF choroidal OCTA offers a new approach to explore choroidal diseases.

  • Categories:Academy
  • Time of issue:2023-07-28 11:56
  • Views:
Information

Conclusion of Prof. Min Wang on TowardPi Webinar:

  1. The evaluation result for retinal vasculature diseases by Ultra-wide-field Swept Source (UWF-SS) OCTA is almost IDENTICAL to UWF-Fundus Fluorescein Angiography (FFA, invasive).
  2. Combination of UWF-SS-OCTA, UWF-Enface and OCT provides more information than FFA.
  3. UWF choroidal OCTA offers a new approach to explore choroidal diseases.

 

*Prof. Min Wang (Eye and ENT Hospital of Fudan University, Shanghai, China) is one of the first ophthalmologists in the world who utilized OCTA in daily practice since year 2014. An international lecturer and author of OCTA application.

Choroidal osteoma captured by BMizar_TowardPi_Prof Min Wang

Choroidal osteoma captured with BMizar, a 400KHz speed SS-OCTA from TowardPi by Prof. Min Wang
 

Prof Min Wang at TowardPi Webinar

Prof. Min Wang at TowardPi Webinar

relevant information

© TowardPi (Beijing) Medical Technology Ltd     京ICP备2021011388号-1   Powered by www.300.cn     View business license